Qiagen N.V. (QGEN)

USD 42.91

(1.39%)

Net Debt Summary of Qiagen N.V.

  • Qiagen N.V.'s latest annual net debt in 2023 was 943.04 Million USD , down -16.6% from previous year.
  • Qiagen N.V.'s latest quarterly net debt in 2024 Q2 was 867.97 Million USD , down -12.3% from previous quarter.
  • Qiagen N.V. reported annual net debt of 1.13 Billion USD in 2022, up 6.55% from previous year.
  • Qiagen N.V. reported annual net debt of 1.06 Billion USD in 2021, down -25.77% from previous year.
  • Qiagen N.V. reported quarterly net debt of 867.97 Million USD for 2024 Q2, down -12.3% from previous quarter.
  • Qiagen N.V. reported quarterly net debt of 943.04 Million USD for 2023 FY, down -16.6% from previous quarter.

Annual Net Debt Chart of Qiagen N.V. (2023 - 1995)

Created with Highcharts 11.1.0YearsNet Debt199619982000200220042006200820102012201420162018202020220 USD500000000 USD1000000000 USD1500000000 USD

Historical Annual Net Debt of Qiagen N.V. (2023 - 1995)

Year Net Debt Net Debt Growth
2023 943.04 Million USD -16.6%
2022 1.13 Billion USD 6.55%
2021 1.06 Billion USD -25.77%
2020 1.42 Billion USD 32.05%
2019 1.08 Billion USD 6.66%
2018 1.01 Billion USD -7.76%
2017 1.1 Billion USD 75.27%
2016 627.91 Million USD -18.41%
2015 769.57 Million USD -1.26%
2014 779.41 Million USD 51.29%
2013 515.18 Million USD 13.74%
2012 452.95 Million USD 22.81%
2011 368.81 Million USD 726.96%
2010 44.59 Million USD -64.44%
2009 125.41 Million USD -80.54%
2008 644.38 Million USD 0.93%
2007 638.47 Million USD 711.62%
2006 78.66 Million USD 342.84%
2005 17.76 Million USD -21.8%
2004 22.71 Million USD -6.89%
2003 24.39 Million USD -62.59%
2002 65.22 Million USD 96.06%
2001 33.26 Million USD 277.71%
2000 8.8 Million USD -58.51%
1999 21.22 Million USD 162.05%
1998 8.1 Million USD 35.0%
1997 6 Million USD -13.04%
1996 6.9 Million USD 187.5%
1995 2.4 Million USD 0.0%

Peer Net Debt Comparison of Qiagen N.V.

Name Net Debt Net Debt Difference
Agilent Technologies, Inc. 1.14 Billion USD 17.638%
Charles River Laboratories International, Inc. 2.78 Billion USD 66.195%
Quest Diagnostics Incorporated 4.68 Billion USD 79.862%
Danaher Corporation 13.67 Billion USD 93.102%
Enzo Biochem, Inc. -52.1 Million USD 1909.851%
IQVIA Holdings Inc. 12.85 Billion USD 92.664%
Laboratory Corporation of America Holdings 5.41 Billion USD 82.592%
Mettler-Toledo International Inc. 2.01 Billion USD 53.107%
Revvity, Inc. 3.11 Billion USD 69.755%
Thermo Fisher Scientific Inc. 26.84 Billion USD 96.486%
Waters Corporation 1.96 Billion USD 51.896%